Methacholine - Sanwa Kagaku Kenkyusho

Drug Profile

Methacholine - Sanwa Kagaku Kenkyusho

Alternative Names: SK 1211

Latest Information Update: 09 Oct 2015

Price : $50

At a glance

  • Originator Sanwa Kagaku Kenkyusho
  • Class Miotics
  • Mechanism of Action Muscarinic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Asthma

Most Recent Events

  • 01 Jul 2014 Phase-III clinical trials in Asthma (Diagnosis, In children) in Japan (Inhalation) (NCT02097537)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top